Emerging studies suggest Retatru tide , a dual activator targeting both the gut-brain axis and glucose-dependent insulinotropic polypeptide , appears to provide a promising advancement for body loss . Initial clinical trials have shown considerable reductions in body fat , possibly surpassing oth